Respiratory Pathogen Testing Market

Respiratory Pathogen Testing Market - Global Industry Analysis 2014 - 2018 and Opportunity Assessment 2019 - 2029

  • Ongoing
  • April 2020
  • REP-GB-10542
  • PDF PPT EXCEL
Respiratory Pathogen Testing Market
  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This Respiratory Pathogen Testing market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Respiratory Pathogen Testing market.


Respiratory pathogen testing is a technique employed to determine the presence of any microorganism that can cause abnormal functioning of respiratory tract, lungs and other components included in respiratory process. Bacteria and viruses make up for most of the respiratory pathogen testing market although some fungi are encountered to be cause for respiratory pathogen testing. The availability of array cards and array plates to determine the presence of load of pathogens is changing the way respiratory pathogen testing conventionally occurred. The new quantitative and qualitative tests developed in the recent past have paved path for new business models in the respiratory pathogen testing market. The multiplex PCR technology is applied to reduce the time required for more specific and reliable respiratory pathogen testing. Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus are the microbes mostly causing for the need of effective respiratory pathogen testing.

Respiratory Pathogen Testing: Market Drivers and Restrains

Lately, usage of respiratory pathogen testing is increasing at a good rate due to rise in various respiratory diseases. According to CDC, the third main cause of death in the U.S. was Chronic Obstructive Pulmonary Diseases (COPD) which is estimated to rise the market of respiratory pathogen testing. The multi-drug resistance portrayed by pathogens over time has increased the need for respiratory pathogen testing market. The rising prevalence of tonsillitis, common cold, influenza, bronchitis, TB and pneumonia are major medical conditions growing recognition for the requirement of respiratory pathogen testing. According to the WHO report focusing on deaths by causes, low-income countries had more deaths due to respiratory infections than strokes and ischemic heart diseases. This can be an opportunity for manufacturers to invest in respiratory pathogen testing devices and kits.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Need granular data and specific insights that are hard to get?

Respiratory Pathogen Testing Market: Overview

The rising dependence on cigarette smoking and illicit drugs makes it easier for the pathogens to enter host system as immunity gets compromised. The increasing number of youths dependent on smoking can be related to rising number of pathogens which will ultimately increase the share of respiratory pathogen testing market. The key players in the market are focusing on the collaborative actions to cater to the volume-based demand of respiratory pathogen testing kits. The need-gap analysis in the different economic regions can help efficient supply chain management of required respiratory pathogen testing market requirements.

Respiratory Pathogen Testing Market: Region-wise Outlook

Globally, North America is anticipated to be the largest contributor of respiratory pathogen testing market.  Increase in epidemics related to gastro intestinal tract infections in low-income countries contribute to the respiratory pathogen testing market. East and South Asia is anticipated to be the second largest market in respiratory pathogen testing. Changing lifestyle and pollution are able to sustain an environment favorable for microbes leading to more respiratory pathogen testing per year in developing as well as developed nations. Europe will also contribute generously to respiratory pathogen testing market with rising healthcare spending on diseases related respiratory pathogen testing market. Middle East & Africa market growth is hindered due to high poverty in the region coupled with lower GDP to healthcare spending ratio. 

Respiratory Pathogen Testing Market: Key Players

Some of the key players present in global respiratory pathogen testing market include Becton Dickinson, Abbott, Koninklijke Philips N.V., Glaxo SmithKline plc, AstraZeneca plc, F. Hoffmann-La Roche Ltd, Vertex Pharmaceuticals Inc, Novartis AG, Boehringer Ingelheim GmbH and Mylan N.V. With active mergers and acquisitions, the respiratory pathogen testing market is changing the structure and presence of various small players active in the respiratory pathogen testing market.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Respiratory Pathogen Testing Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Respiratory Pathogen Testing Market: Segmentation

Respiratory Pathogen Testing Segmentation by Product Type:

  • Test Kits for bacterial respiratory pathogen testing
  • Test kits for viral respiratory pathogen testing
  • Others

Respiratory Pathogen Testing Segmentation by Target:

  • Influenza virus
  • Coronavirus
  • Mycoplasma pneumoniae
  • Staphylococcus aureus
  • Salmonella spp
  • Pneumocystis jirovecii

Segmentation by End User Type:

  • Hospitals
  • Clinics
  • Diagnostic Laboratories

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Respiratory Pathogen Testing Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Respiratory Pathogen Testing Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields
Our Clients

Request Sample Request customization Request Methodology